Table 1. Significant interactions affecting HDL-C levels validated in multiple population cohorts.
Test Stage | Cohort | SNP 1 | SNP 2 | P c c | ||||||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
rsID | Chr | Posa | Geneb | rsID | Chr | Posa | Geneb | |||
Discovery | ARIC EA | rs12916 | 5 | 74656539 | HMGCR (3’ UTR) | rs1532085 | 15 | 58683366 | 40.8k U LIPC | 0.008 |
Fine Mapping | ARIC EA | rs3846662 | 5 | 74651084 | HMGCR (Intron) | rs2043085 | 15 | 58680954 | 43.2k U LIPC | 0.002 |
Validation | MESA EA | rs3846662 | 5 | 74651084 | HMGCR (Intron) | rs1973688 | 15 | 58582540 | 141.6k U LIPC | 0.006 |
Validation | FHS EA | rs55727654 | 5 | 74651864 | HMGCR (Intron) | rs473422 | 15 | 58666341 | 57.8k U LIPC | 0.002 |
Validation | MESA HA | rs1423527 | 5 | 74602699 | 30.3k U HMGCR | rs7163280 | 15 | 58718340 | 5.8k U LIPC | 0.04 |
Validation | ARIC AA | rs3761743 | 5 | 74685520 | 27.6k D HMGCR | rs567838 | 15 | 58736623 | LIPC (Intron) | 0.004 |
Build 37.1 (GRCh37)
U = upstream of; D = downstream of
P-value after Bonferroni correction